Q & A: Dr. Xiao Wei, 2018 KCA Grant Recipient
In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research.
In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research.
See the latest #NSCLC #immunotherapy live event from @PeerView @PatelOncology @DoctorJSpicer #ASCO24 #MedEd
The report identifies key themes from investigations where safety recommendations were made to midwife led units in NHS hospital trusts.
The biologist Alfonso Martínez Arias defends that genes do not define the uniqueness of a person, citing the example of Karen Keegan, who has two…
A re-analysis of the SWOG S1801 trial (neoadjuvant pembrolizumab versus adjuvant only), and more…
By Nausheen Ahmed, Olalekan Oluwole & 3 more. We recommend re-immunizing patients post CAR-T based on CDC and transplant guidelines.
Some doctors are promoting propellant-free inhalers over puff inhalers that emit greenhouse gases. Climate change can exacerbate respiratory ills because of more fires, air pollution…
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
Mayo Clinic’s PragMMatic Study Accruing Newly Diagnosed Multiple Myeloma Patients A new clinical trial administered by the Mayo Clinic, the PragMMatic Study, is now accruing newly…
TPS9605 Background: Adjuvant treatment with anti-PD1 therapy improves the recurrence free survival (RFS) in resectable stage III melanoma. The Checkmate-238 and KEYNOTE-054 trials respectively reported…
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…